1 | progression-free | 3,508 |
2 | disease-free | 2,161 |
3 | event-free | 861 |
4 | recurrence-free | 490 |
5 | relapse-free | 399 |
6 | metastasis-free | 123 |
7 | failure-free | 114 |
8 | transplant-free | 55 |
9 | infection-free | 51 |
10 | leukemia-free | 44 |
11 | tumor-free | 44 |
12 | post-progression | 36 |
13 | af-free | 35 |
14 | hiv-free | 30 |
15 | amputation-free | 28 |
16 | disability-free | 25 |
17 | aids-free | 24 |
18 | hospitalization-free | 24 |
19 | post-relapse | 21 |
20 | transplantation-free | 21 |
21 | postprogression | 20 |
22 | tumour-free | 20 |
23 | ulcer-free | 19 |
24 | mace-free | 18 |
25 | melanoma-specific | 18 |
26 | hospital-free | 17 |
27 | bos-free | 16 |
28 | dialysis-free | 14 |
29 | tracheostomy-free | 13 |
30 | patient/graft | 10 |
31 | distant-disease-free | 9 |
32 | metastases-free | 9 |
33 | hiv-1-free | 7 |
34 | puncture-free | 7 |
35 | therapy-free | 7 |
36 | arrhythmia-free | 6 |
37 | gvhd-free | 6 |
38 | hf-free | 6 |
39 | leukaemia-free | 6 |
40 | bcr-free | 5 |
41 | induction-expulsion | 5 |
42 | colostomy-free | 4 |
43 | disease-free/progression-free | 4 |
44 | macce-free | 4 |
45 | postmetastasis | 4 |
46 | progress-free | 4 |
47 | rebleeding-free | 4 |
48 | shock-free | 4 |
49 | bone-metastasis-free | 3 |
50 | colectomy-free | 3 |
51 | dysfunction-free | 3 |
52 | graft/patient | 3 |
53 | postexplant | 3 |
54 | postthawing | 3 |
55 | progressionfree | 3 |
56 | readmission-free | 3 |
57 | recurrence‑free | 3 |
58 | survival/overall | 3 |
59 | thrombosis-free | 3 |
60 | toxicity-free | 3 |
61 | 10th-year | 2 |
62 | af-/afl-free | 2 |
63 | ami-free | 2 |
64 | aml-free | 2 |
65 | amp-free | 2 |
66 | biopsy-cone | 2 |
67 | catheter-dependent | 2 |
68 | device-free | 2 |
69 | df-free | 2 |
70 | distant-metastasis-free | 2 |
71 | dysplasia/cancer-free | 2 |
72 | encephalopathy-free | 2 |
73 | events-free | 2 |
74 | exposure-specific | 2 |
75 | fungal-free | 2 |
76 | htx-free | 2 |
77 | infarct-free | 2 |
78 | institutional-free | 2 |
79 | laryngectomy-free | 2 |
80 | ltx-free | 2 |
81 | lymphoma-specific | 2 |
82 | oxygenation-free | 2 |
83 | pca-free | 2 |
84 | progressive-free | 2 |
85 | restenosis-free | 2 |
86 | restricture-free | 2 |
87 | sgn | 2 |
88 | signal-specific | 2 |
89 | syndrome-free | 2 |
90 | ta-free | 2 |
91 | transformation-free | 2 |
92 | 1000-day | 1 |
93 | 3-year-disease-free | 1 |
94 | 60.09 | 1 |
95 | ad-free | 1 |
96 | adt-free | 1 |
97 | allograft/patient | 1 |
98 | anemia-readmission-free | 1 |
99 | antigen-free | 1 |
100 | att-art | 1 |
101 | bacteremia-free | 1 |
102 | bc-specific | 1 |
103 | better-adjusted | 1 |
104 | bexarotene-improved | 1 |
105 | bp-free | 1 |
106 | br-free | 1 |
107 | call-arrival | 1 |
108 | capsulotomy-free | 1 |
109 | carboplatin.relative | 1 |
110 | carvedilol-improves | 1 |
111 | chemotherapy.overall | 1 |
112 | chf-free | 1 |
113 | clinical-progression-free | 1 |
114 | cutler-ederer | 1 |
115 | disease-fee | 1 |
116 | during-winter | 1 |
117 | enlonging | 1 |
118 | free-progression | 1 |
119 | handicap-free | 1 |
120 | hypertension-free | 1 |
121 | idr-free | 1 |
122 | inter-stimulation | 1 |
123 | ischemia-inducible | 1 |
124 | kta-specific | 1 |
125 | larval/post-larval | 1 |
126 | level.disease-free | 1 |
127 | local-disease-free | 1 |
128 | locoregional-recurrence-free | 1 |
129 | longerprogression-free | 1 |
130 | lrr-free | 1 |
131 | ltb4-afforded | 1 |
132 | ltp-free | 1 |
133 | lung-transplantation-free | 1 |
134 | mace- | 1 |
135 | mechanical-ventilation-free | 1 |
136 | metastatic-free | 1 |
137 | multiple-deprivations | 1 |
138 | non-mace | 1 |
139 | nutrition-support-free | 1 |
140 | oncosurgical | 1 |
141 | pah-event-free | 1 |
142 | paracentesis-free | 1 |
143 | pectoris-free | 1 |
144 | performance-free | 1 |
145 | points-overall | 1 |
146 | post-developmental | 1 |
147 | post-fledging | 1 |
148 | post-mht | 1 |
149 | post-shunt | 1 |
150 | postoperative-day | 1 |
151 | prostaglandin-abortion | 1 |
152 | psychosis-free | 1 |
153 | re-recurrence-free | 1 |
154 | recurrence/progression-free | 1 |
155 | recurrence–free | 1 |
156 | recurrent-free | 1 |
157 | regression-free | 1 |
158 | resection-free | 1 |
159 | respectively.median | 1 |
160 | retreatment-free | 1 |
161 | revascularization-free | 1 |
162 | scc-free | 1 |
163 | sepsis-free | 1 |
164 | sm-free | 1 |
165 | stage-associated | 1 |
166 | survival/relapse-free | 1 |
167 | t-year | 1 |
168 | tn-free | 1 |
169 | transplantation-conversion | 1 |
170 | transport-28-day | 1 |
171 | tuberculosis-disease-free | 1 |
172 | tuberculosis-free | 1 |
173 | tuberculosis-infection-free | 1 |
174 | uht-free | 1 |
175 | urosepsis-free | 1 |
176 | viremia-free | 1 |
177 | young-of-the-year | 1 |
1 | 1000-day | 1 |
2 | 10th-year | 2 |
3 | 3-year-disease-free | 1 |
4 | 60.09 | 1 |
5 | ad-free | 1 |
6 | adt-free | 1 |
7 | af-/afl-free | 2 |
8 | af-free | 35 |
9 | aids-free | 24 |
10 | allograft/patient | 1 |
11 | ami-free | 2 |
12 | aml-free | 2 |
13 | amp-free | 2 |
14 | amputation-free | 28 |
15 | anemia-readmission-free | 1 |
16 | antigen-free | 1 |
17 | arrhythmia-free | 6 |
18 | att-art | 1 |
19 | bacteremia-free | 1 |
20 | bc-specific | 1 |
21 | bcr-free | 5 |
22 | better-adjusted | 1 |
23 | bexarotene-improved | 1 |
24 | biopsy-cone | 2 |
25 | bone-metastasis-free | 3 |
26 | bos-free | 16 |
27 | bp-free | 1 |
28 | br-free | 1 |
29 | call-arrival | 1 |
30 | capsulotomy-free | 1 |
31 | carboplatin.relative | 1 |
32 | carvedilol-improves | 1 |
33 | catheter-dependent | 2 |
34 | chemotherapy.overall | 1 |
35 | chf-free | 1 |
36 | clinical-progression-free | 1 |
37 | colectomy-free | 3 |
38 | colostomy-free | 4 |
39 | cutler-ederer | 1 |
40 | device-free | 2 |
41 | df-free | 2 |
42 | dialysis-free | 14 |
43 | disability-free | 25 |
44 | disease-fee | 1 |
45 | disease-free | 2,161 |
46 | disease-free/progression-free | 4 |
47 | distant-disease-free | 9 |
48 | distant-metastasis-free | 2 |
49 | during-winter | 1 |
50 | dysfunction-free | 3 |
51 | dysplasia/cancer-free | 2 |
52 | encephalopathy-free | 2 |
53 | enlonging | 1 |
54 | event-free | 861 |
55 | events-free | 2 |
56 | exposure-specific | 2 |
57 | failure-free | 114 |
58 | free-progression | 1 |
59 | fungal-free | 2 |
60 | graft/patient | 3 |
61 | gvhd-free | 6 |
62 | handicap-free | 1 |
63 | hf-free | 6 |
64 | hiv-1-free | 7 |
65 | hiv-free | 30 |
66 | hospital-free | 17 |
67 | hospitalization-free | 24 |
68 | htx-free | 2 |
69 | hypertension-free | 1 |
70 | idr-free | 1 |
71 | induction-expulsion | 5 |
72 | infarct-free | 2 |
73 | infection-free | 51 |
74 | institutional-free | 2 |
75 | inter-stimulation | 1 |
76 | ischemia-inducible | 1 |
77 | kta-specific | 1 |
78 | larval/post-larval | 1 |
79 | laryngectomy-free | 2 |
80 | leukaemia-free | 6 |
81 | leukemia-free | 44 |
82 | level.disease-free | 1 |
83 | local-disease-free | 1 |
84 | locoregional-recurrence-free | 1 |
85 | longerprogression-free | 1 |
86 | lrr-free | 1 |
87 | ltb4-afforded | 1 |
88 | ltp-free | 1 |
89 | ltx-free | 2 |
90 | lung-transplantation-free | 1 |
91 | lymphoma-specific | 2 |
92 | macce-free | 4 |
93 | mace- | 1 |
94 | mace-free | 18 |
95 | mechanical-ventilation-free | 1 |
96 | melanoma-specific | 18 |
97 | metastases-free | 9 |
98 | metastasis-free | 123 |
99 | metastatic-free | 1 |
100 | multiple-deprivations | 1 |
101 | non-mace | 1 |
102 | nutrition-support-free | 1 |
103 | oncosurgical | 1 |
104 | oxygenation-free | 2 |
105 | pah-event-free | 1 |
106 | paracentesis-free | 1 |
107 | patient/graft | 10 |
108 | pca-free | 2 |
109 | pectoris-free | 1 |
110 | performance-free | 1 |
111 | points-overall | 1 |
112 | post-developmental | 1 |
113 | post-fledging | 1 |
114 | post-mht | 1 |
115 | post-progression | 36 |
116 | post-relapse | 21 |
117 | post-shunt | 1 |
118 | postexplant | 3 |
119 | postmetastasis | 4 |
120 | postoperative-day | 1 |
121 | postprogression | 20 |
122 | postthawing | 3 |
123 | progress-free | 4 |
124 | progression-free | 3,508 |
125 | progressionfree | 3 |
126 | progressive-free | 2 |
127 | prostaglandin-abortion | 1 |
128 | psychosis-free | 1 |
129 | puncture-free | 7 |
130 | re-recurrence-free | 1 |
131 | readmission-free | 3 |
132 | rebleeding-free | 4 |
133 | recurrence-free | 490 |
134 | recurrence/progression-free | 1 |
135 | recurrence‑free | 3 |
136 | recurrence–free | 1 |
137 | recurrent-free | 1 |
138 | regression-free | 1 |
139 | relapse-free | 399 |
140 | resection-free | 1 |
141 | respectively.median | 1 |
142 | restenosis-free | 2 |
143 | restricture-free | 2 |
144 | retreatment-free | 1 |
145 | revascularization-free | 1 |
146 | scc-free | 1 |
147 | sepsis-free | 1 |
148 | sgn | 2 |
149 | shock-free | 4 |
150 | signal-specific | 2 |
151 | sm-free | 1 |
152 | stage-associated | 1 |
153 | survival/overall | 3 |
154 | survival/relapse-free | 1 |
155 | syndrome-free | 2 |
156 | t-year | 1 |
157 | ta-free | 2 |
158 | therapy-free | 7 |
159 | thrombosis-free | 3 |
160 | tn-free | 1 |
161 | toxicity-free | 3 |
162 | tracheostomy-free | 13 |
163 | transformation-free | 2 |
164 | transplant-free | 55 |
165 | transplantation-conversion | 1 |
166 | transplantation-free | 21 |
167 | transport-28-day | 1 |
168 | tuberculosis-disease-free | 1 |
169 | tuberculosis-free | 1 |
170 | tuberculosis-infection-free | 1 |
171 | tumor-free | 44 |
172 | tumour-free | 20 |
173 | uht-free | 1 |
174 | ulcer-free | 19 |
175 | urosepsis-free | 1 |
176 | viremia-free | 1 |
177 | young-of-the-year | 1 |
1 | mace- | 1 |
2 | 60.09 | 1 |
3 | lymphoma-specific | 2 |
4 | melanoma-specific | 18 |
5 | kta-specific | 1 |
6 | bc-specific | 1 |
7 | exposure-specific | 2 |
8 | signal-specific | 2 |
9 | ltb4-afforded | 1 |
10 | stage-associated | 1 |
11 | better-adjusted | 1 |
12 | bexarotene-improved | 1 |
13 | non-mace | 1 |
14 | disease-fee | 1 |
15 | hiv-1-free | 7 |
16 | pca-free | 2 |
17 | leukaemia-free | 6 |
18 | leukemia-free | 44 |
19 | bacteremia-free | 1 |
20 | viremia-free | 1 |
21 | arrhythmia-free | 6 |
22 | ta-free | 2 |
23 | scc-free | 1 |
24 | metastatic-free | 1 |
25 | ad-free | 1 |
26 | gvhd-free | 6 |
27 | mace-free | 18 |
28 | macce-free | 4 |
29 | device-free | 2 |
30 | performance-free | 1 |
31 | recurrence-free | 490 |
32 | re-recurrence-free | 1 |
33 | locoregional-recurrence-free | 1 |
34 | syndrome-free | 2 |
35 | failure-free | 114 |
36 | restricture-free | 2 |
37 | puncture-free | 7 |
38 | disease-free | 2,161 |
39 | local-disease-free | 1 |
40 | 3-year-disease-free | 1 |
41 | tuberculosis-disease-free | 1 |
42 | distant-disease-free | 9 |
43 | level.disease-free | 1 |
44 | relapse-free | 399 |
45 | survival/relapse-free | 1 |
46 | progressive-free | 2 |
47 | af-free | 35 |
48 | df-free | 2 |
49 | hf-free | 6 |
50 | chf-free | 1 |
51 | rebleeding-free | 4 |
52 | ami-free | 2 |
53 | shock-free | 4 |
54 | fungal-free | 2 |
55 | institutional-free | 2 |
56 | hospital-free | 17 |
57 | af-/afl-free | 2 |
58 | aml-free | 2 |
59 | sm-free | 1 |
60 | antigen-free | 1 |
61 | hypertension-free | 1 |
62 | regression-free | 1 |
63 | progression-free | 3,508 |
64 | clinical-progression-free | 1 |
65 | recurrence/progression-free | 1 |
66 | disease-free/progression-free | 4 |
67 | longerprogression-free | 1 |
68 | readmission-free | 3 |
69 | anemia-readmission-free | 1 |
70 | mechanical-ventilation-free | 1 |
71 | transformation-free | 2 |
72 | oxygenation-free | 2 |
73 | transplantation-free | 21 |
74 | lung-transplantation-free | 1 |
75 | amputation-free | 28 |
76 | hospitalization-free | 24 |
77 | revascularization-free | 1 |
78 | infection-free | 51 |
79 | tuberculosis-infection-free | 1 |
80 | resection-free | 1 |
81 | dysfunction-free | 3 |
82 | tn-free | 1 |
83 | handicap-free | 1 |
84 | bp-free | 1 |
85 | amp-free | 2 |
86 | ltp-free | 1 |
87 | br-free | 1 |
88 | bcr-free | 5 |
89 | idr-free | 1 |
90 | ulcer-free | 19 |
91 | dysplasia/cancer-free | 2 |
92 | tumor-free | 44 |
93 | lrr-free | 1 |
94 | tumour-free | 20 |
95 | aids-free | 24 |
96 | metastases-free | 9 |
97 | pectoris-free | 1 |
98 | metastasis-free | 123 |
99 | bone-metastasis-free | 3 |
100 | distant-metastasis-free | 2 |
101 | paracentesis-free | 1 |
102 | thrombosis-free | 3 |
103 | psychosis-free | 1 |
104 | tuberculosis-free | 1 |
105 | restenosis-free | 2 |
106 | sepsis-free | 1 |
107 | urosepsis-free | 1 |
108 | dialysis-free | 14 |
109 | bos-free | 16 |
110 | progress-free | 4 |
111 | events-free | 2 |
112 | infarct-free | 2 |
113 | adt-free | 1 |
114 | uht-free | 1 |
115 | transplant-free | 55 |
116 | retreatment-free | 1 |
117 | recurrent-free | 1 |
118 | event-free | 861 |
119 | pah-event-free | 1 |
120 | nutrition-support-free | 1 |
121 | hiv-free | 30 |
122 | htx-free | 2 |
123 | ltx-free | 2 |
124 | encephalopathy-free | 2 |
125 | laryngectomy-free | 2 |
126 | colectomy-free | 3 |
127 | capsulotomy-free | 1 |
128 | tracheostomy-free | 13 |
129 | colostomy-free | 4 |
130 | therapy-free | 7 |
131 | toxicity-free | 3 |
132 | disability-free | 25 |
133 | progressionfree | 3 |
134 | recurrence‑free | 3 |
135 | recurrence–free | 1 |
136 | ischemia-inducible | 1 |
137 | biopsy-cone | 2 |
138 | post-relapse | 21 |
139 | carboplatin.relative | 1 |
140 | post-fledging | 1 |
141 | enlonging | 1 |
142 | postthawing | 3 |
143 | oncosurgical | 1 |
144 | post-developmental | 1 |
145 | call-arrival | 1 |
146 | larval/post-larval | 1 |
147 | points-overall | 1 |
148 | chemotherapy.overall | 1 |
149 | survival/overall | 3 |
150 | respectively.median | 1 |
151 | sgn | 2 |
152 | induction-expulsion | 5 |
153 | transplantation-conversion | 1 |
154 | free-progression | 1 |
155 | post-progression | 36 |
156 | postprogression | 20 |
157 | inter-stimulation | 1 |
158 | prostaglandin-abortion | 1 |
159 | young-of-the-year | 1 |
160 | 10th-year | 2 |
161 | t-year | 1 |
162 | cutler-ederer | 1 |
163 | during-winter | 1 |
164 | carvedilol-improves | 1 |
165 | postmetastasis | 4 |
166 | multiple-deprivations | 1 |
167 | patient/graft | 10 |
168 | post-mht | 1 |
169 | postexplant | 3 |
170 | catheter-dependent | 2 |
171 | graft/patient | 3 |
172 | allograft/patient | 1 |
173 | post-shunt | 1 |
174 | att-art | 1 |
175 | 1000-day | 1 |
176 | transport-28-day | 1 |
177 | postoperative-day | 1 |